North America Ocular Drug Delivery Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)

No. of Pages: 147    |    Report Code: TIPRE00025761    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Ocular Drug Delivery Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Ocular Drug Delivery Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Ocular Drug Delivery Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Advances in ocular drug delivery technologies
  • 5.1.2 Growth in demand for non-invasive drug delivery systems
5.2 Market Opportunities
  • 5.2.1 Expansion in ophthalmic drug delivery market
  • 5.2.2 Growth in demand for effective ocular treatments
5.3 Future Trends
  • 5.3.1 Development of novel ocular drug delivery systems
  • 5.3.2 Rise in demand for sustained-release eye treatments
5.4 Impact of Drivers and Restraints

6. North America Ocular Drug Delivery Market Regional Analysis

6.1 North America Ocular Drug Delivery Market Overview
6.2 North America Ocular Drug Delivery Market Revenue 2019-2028 (US$ Million)
6.3 North America Ocular Drug Delivery Market Forecast Analysis

7. North America Ocular Drug Delivery Market Analysis – by Technology

7.1 Implantable Ocular Drug Delivery Systems
  • 7.1.1 Overview
  • 7.1.2 Implantable Ocular Drug Delivery Systems: North America Ocular Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Particulate Drug Delivery Systems
  • 7.2.1 Overview
  • 7.2.2 Particulate Drug Delivery Systems: North America Ocular Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Nano-Particle Drug Delivery System
  • 7.3.1 Overview
  • 7.3.2 Nano-Particle Drug Delivery System: North America Ocular Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Ocular Drug Delivery Market Analysis – by Formulation Type

8.1 Liposomes and Nanoparticles
  • 8.1.1 Overview
  • 8.1.2 Liposomes and Nanoparticles: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Solution
  • 8.2.1 Overview
  • 8.2.2 Solution: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Emulsion
  • 8.3.1 Overview
  • 8.3.2 Emulsion: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Suspension
  • 8.4.1 Overview
  • 8.4.2 Suspension: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ointment
  • 8.5.1 Overview
  • 8.5.2 Ointment: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Ocular Drug Delivery Market Analysis – by Disease Type

9.1 Glaucoma
  • 9.1.1 Overview
  • 9.1.2 Ointment: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Diabetic Retinopathy
  • 9.2.1 Overview
  • 9.2.2 Ointment: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Dry Eye Syndrome
  • 9.3.1 Overview
  • 9.3.2 Ointment: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Macular Degeneration
  • 9.4.1 Overview
  • 9.4.2 Ointment: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cataract
  • 9.5.1 Overview
  • 9.5.2 Ointment: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Diabetic Macular Edema
  • 9.6.1 Overview
  • 9.6.2 Ointment: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Ocular Drug Delivery Market – North America Analysis

10.1 North America
  • 10.1.1 North America Ocular Drug Delivery Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Ocular Drug Delivery Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Ocular Drug Delivery Market Breakdown, by Technology
    • 10.1.1.1.2 US: North America Ocular Drug Delivery Market Breakdown, by Formulation Type
    • 10.1.1.1.3 US: North America Ocular Drug Delivery Market Breakdown, by Disease Type
  • 10.1.1.2 Canada: North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Ocular Drug Delivery Market Breakdown, by Technology
    • 10.1.1.2.2 Canada: North America Ocular Drug Delivery Market Breakdown, by Formulation Type
    • 10.1.1.2.3 Canada: North America Ocular Drug Delivery Market Breakdown, by Disease Type
  • 10.1.1.3 Mexico : North America Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Ocular Drug Delivery Market Breakdown, by Technology
    • 10.1.1.3.2 Mexico : North America Ocular Drug Delivery Market Breakdown, by Formulation Type
    • 10.1.1.3.3 Mexico : North America Ocular Drug Delivery Market Breakdown, by Disease Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Ocular Drug Delivery Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AbbVie Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bausch Health Companies Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Novartis AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Clearside Biomedical, Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Ocular Therapeutix, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Envisia Therapeutics
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Alimera Sciences, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 EYEGATE PHARMACEUTICALS, INC
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. AbbVie Inc.                                              
  2. Bausch Health Companies Inc.            
  3. Novartis AG                                            
  4. Clearside Biomedical, Inc                      
  5. Ocular Therapeutix, Inc.                       
  6. Envisia Therapeutics                             
  7. Alimera Sciences, Inc.                           
  8. EYEGATE PHARMACEUTICALS, INC                                                            
north-america-ocular-drug-delivery-market